Summary by Moomoo AI
On April 5, 2024, a Schedule 13G filing was made with the United States Securities and Exchange Commission (SEC) indicating that ADAR1 Partners, LP, along with related entities and Daniel Schneeberger, collectively reported a 9.27% ownership stake in iBio Inc. The shares in question amount to 789,293 shares of common stock. ADAR1 Partners, LP is directly holding the shares, while ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, both managed by Daniel Schneeberger, may be deemed to indirectly beneficially own the securities. The filing, which is based on the number of shares outstanding as reported on April 1, 2024, does not imply any intention to change or influence the control of iBio Inc. The principal business office for the reporting persons is located in Austin, Texas, and the filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934.